BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9422410)

  • 1. Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease.
    Goldfarb DA; Neumann HP; Penn I; Novick AC
    Transplantation; 1997 Dec; 64(12):1726-9. PubMed ID: 9422410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease.
    Steinbach F; Novick AC; Shoskes D
    Urology; 1994 Nov; 44(5):760-3. PubMed ID: 7974953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of and indications for renal transplantation in patients with von Hippel Lindau disease.
    Antony MB; Rompré-Brodeur A; Chaurasia A; Ryan B; Gopal N; Kozel Z; Linehan WM; Ball MW
    Urol Oncol; 2023 Dec; 41(12):487.e1-487.e6. PubMed ID: 37778955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephron-sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease.
    Goldfarb DA
    J Intern Med; 1998 Jun; 243(6):563-7. PubMed ID: 9681859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative surgical therapy of localized renal cell carcinoma in von Hippel-Lindau disease.
    Lund GO; Fallon B; Curtis MA; Williams RD
    Cancer; 1994 Nov; 74(9):2541-5. PubMed ID: 7923011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study.
    Steinbach F; Novick AC; Zincke H; Miller DP; Williams RD; Lund G; Skinner DG; Esrig D; Richie JP; deKernion JB
    J Urol; 1995 Jun; 153(6):1812-6. PubMed ID: 7752324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of renal-cell carcinoma in von Hippel-Lindau disease].
    Uscanga-Yépez J; Rodríguez-Covarrubias F; Morales J; Granados J; Gabilondo-Navarro F
    Rev Invest Clin; 2013; 65(4):318-22. PubMed ID: 24304732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of localized renal cell carcinoma in von Hippel-Lindau's disease.
    Spencer WF; Novick AC; Montie JE; Streem SB; Levin HS
    J Urol; 1988 Mar; 139(3):507-9. PubMed ID: 3278131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
    Ploussard G; Droupy S; Ferlicot S; Ples R; Rocher L; Richard S; Benoit G
    Urology; 2007 Sep; 70(3):435-9. PubMed ID: 17905091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
    Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
    J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of von Hippel-Lindau disease: urologic considerations.
    Reed AB; Parekh DJ
    Surg Oncol Clin N Am; 2009 Jan; 18(1):157-74, x. PubMed ID: 19056047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.
    Walther MM; Choyke PL; Glenn G; Lyne JC; Rayford W; Venzon D; Linehan WM
    J Urol; 1999 May; 161(5):1475-9. PubMed ID: 10210376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience.
    Roupret M; Hopirtean V; Mejean A; Thiounn N; Dufour B; Chretien Y; Chauveau D; Richard S
    J Urol; 2003 Nov; 170(5):1752-5. PubMed ID: 14532769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation in Lindau-von Hippel Disease.
    Peterson GJ; Codd JE; Cuddihee RE; Newton WT
    Arch Surg; 1977 Jul; 112(7):841-2. PubMed ID: 327975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
    Choueiri TK; Vaziri SA; Jaeger E; Elson P; Wood L; Bhalla IP; Small EJ; Weinberg V; Sein N; Simko J; Golshayan AR; Sercia L; Zhou M; Waldman FM; Rini BI; Bukowski RM; Ganapathi R
    J Urol; 2008 Sep; 180(3):860-5; discussion 865-6. PubMed ID: 18635227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
    Duffey BG; Choyke PL; Glenn G; Grubb RL; Venzon D; Linehan WM; Walther MM
    J Urol; 2004 Jul; 172(1):63-5. PubMed ID: 15201738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urological management of patients with von Hippel-Lindau's disease.
    Loughlin KR; Gittes RF
    J Urol; 1986 Oct; 136(4):789-91. PubMed ID: 3761431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
    Park BK; Kim CK
    J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.